Mika Casey

Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Journal: Nature immunology
Published: February 15, 2024

Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy.

Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy.

Journal: Haematologica
Published: October 30, 2023

Regulatory T cells hamper the efficacy of T-cell-engaging bispecific antibody therapy.

Regulatory T cells hamper the efficacy of T-cell-engaging bispecific antibody therapy.

Journal: Haematologica
Published: June 14, 2023

Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.

Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.

Journal: Leukemia
Published: September 30, 2022

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA.

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA.

Journal: Blood advances
Published: May 17, 2022

A simple organic solvent precipitation method to improve detection of low molecular weight proteins.

A simple organic solvent precipitation method to improve detection of low molecular weight proteins.

Journal: Proteomics
Published: June 21, 2021

The Cancer-Immunity Cycle in Multiple Myeloma.

The Cancer-Immunity Cycle in Multiple Myeloma.

Journal: ImmunoTargets and therapy
Published: June 01, 2021

Targeting an adenosine-mediated "don't eat me signal" augments anti-lymphoma immunity by anti-CD20 monoclonal antibody.

Targeting an adenosine-mediated "don't eat me signal" augments anti-lymphoma immunity by anti-CD20 monoclonal antibody.

Journal: Leukemia
Published: December 07, 2019

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.

CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.

Journal: Immunity
Published: September 25, 2019

The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Journal: Nature immunology
Published: August 15, 2019

Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model.

Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model.

Journal: JCI insight
Published: June 14, 2019

Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma.

Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma.

Journal: Redox biology
Published: June 12, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026